Roivant Sciences (ROIV) Other Accumulated Expenses (2021 - 2026)

Roivant Sciences' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $583000.0 for Q1 2026.

• Quarterly Other Accumulated Expenses fell 50.09% year-over-year to $583000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $583000.0 (down 50.09% YoY) and the FY2026 annual result came in at $583000.0, down 50.09% from the prior year.
• Other Accumulated Expenses was $583000.0 for Q1 2026 at Roivant Sciences, down from $10.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $76.3 million in Q1 2023 and bottomed at $583000.0 in Q1 2026.
• A 5-year average of $31.8 million and a median of $27.5 million in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses jumped 602.7% — and 2025, when it plunged 97.38%.
• Roivant Sciences' Other Accumulated Expenses stood at $14.3 million in 2022, then jumped by 204.87% to $43.6 million in 2023, then gained by 22.55% to $53.5 million in 2024, then plunged by 80.84% to $10.2 million in 2025, then slumped by 94.31% to $583000.0 in 2026.
• Business Quant data shows ROIV's Other Accumulated Expenses at $583000.0 in Q1 2026, $10.2 million in Q4 2025, and $1.5 million in Q3 2025.